Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria
about
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment ResponseThe Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersRadiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysisVolumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumorsFunctional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.Hypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance ImagingIntraarterial therapies for primary liver cancer: state of the art.Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.New concepts in embolotherapy of HCC.Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly.Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy
P2860
Q26740616-09C847F7-03B0-4E5A-8548-CB92A1FA35D6Q26768460-CAFB4484-CB99-4A24-B77D-E3D9FDBED2A9Q34680081-4CB08CA1-4836-4111-89DA-A804C65A2D11Q35073497-4FCE5F1A-FD25-415E-ABCC-82AE5CB8A81BQ35096126-C3086D5D-75D2-41AA-B8E4-D6DFB4D6A0DDQ35163735-778443F4-3456-4965-8B7A-FE8F5672FB28Q35234472-862FEF2E-263B-4AD9-B318-1DC562C89952Q35732421-73AB5FE4-125B-46B8-87D7-FBF2B05F35D3Q36416250-445022FE-3A5F-4C4A-92D0-6426C7DDC633Q37221919-9C588427-88A3-4E10-A839-9D4EB5739300Q38149993-270E3750-A30B-4C4F-8B39-59D5688431CBQ38172834-56020B2A-3A92-4497-80DE-83895EF9CCE0Q38265114-891F87A7-672B-401E-8E0D-67D56C62B223Q38904263-6436A842-539B-497E-9CD0-30A480A0BBD4Q38922919-7F13FED2-A463-4C29-8797-02207E0050A4Q40110698-ABFB4AF2-B194-4A49-B55B-7CF39A5E2135Q53089236-6C4855ED-FD4C-4040-B407-96D6A5F3CA89Q57490366-8D484F5D-824E-4C11-8BBA-0E22EE27E49D
P2860
Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unresectable hepatocellular ca ...... c functional response criteria
@en
Unresectable hepatocellular ca ...... functional response criteria.
@nl
type
label
Unresectable hepatocellular ca ...... c functional response criteria
@en
Unresectable hepatocellular ca ...... functional response criteria.
@nl
prefLabel
Unresectable hepatocellular ca ...... c functional response criteria
@en
Unresectable hepatocellular ca ...... functional response criteria.
@nl
P2093
P2860
P356
P1433
P1476
Unresectable hepatocellular ca ...... c functional response criteria
@en
P2093
Celia Pamela Corona-Villalobos
David Bonekamp
Diane Reyes
Ihab R Kamel
Jean-François H Geschwind
Susanne Bonekamp
Vivek Gowdra Halappa
P2860
P304
P356
10.1148/RADIOL.13122307
P407
P577
2013-04-24T00:00:00Z